Carbylan Therapeutics carbylan.com


Carbylan Therapeutics is a clinical-stage, specialty, pharmaceutical company focused on the development and commercialization of proprietary combination therapies that address significant unmet medical needs. The company's initial focus is on the development of Hydros-TA, their proprietary, intra-articular injectable product candidate to treat pain associated with osteoarthritis of the knee. Carbylan Therapeutics previously traded on the Nasdaq Stock Market under the ticker CBYL.

Carbylan Therapeutics is a clinical-stage, specialty, pharmaceutical company focused on the development and commercialization of proprietary combination therapies that address significant unmet medical needs. The company's initial focus is on the dev...Show all

Company (Acquired)

Phone: 510-933-8365

Fax:

39899 Balentine Drive
Suite 200
Newark, 94560
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Carbylan Therapeutics $107.8M Nov 22, 2016
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Carbylan Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
InterWest PartnersVenture CapitalMenlo Park, California, United StatesSeries C, Series B, Series A
Alta PartnersVenture CapitalSan Francisco, California, United StatesSeries C, Series B, Series A
Vivo CapitalVenture CapitalPalo Alto, California, United StatesSeries C, Series B
Undisclosed InvestorsOtherDebt - II, Debt
See all 4 investors

Competitors

Company Status Description Investors
See all 16 competitors